Treace Medical Concepts announced successful completion of the first case utilizing its Lapiplasty Lightning technology.
Lightning technology expands upon Treace’s Lapiplasty System with advanced new instrumentation designed to reduce surgical steps, correct in all three planes, and further streamline procedural workflow with Treace’s SpeedPlate Rapid Compression Fixation technology.
“As the pioneers and leaders in instrumented 3D bunion correction, Lightning technology demonstrates our commitment to continuous advancement of our patented Lapiplasty® System, improving surgical efficiency and precision and expanding its appeal to more surgeons,” said John T. Treace, CEO and Chairman of Treace. “We anticipate initiating our limited market release of the Lapiplasty® Lightning™ System midyear 2026 in advance of full commercialization, which we expect before the end of year.”
Treace Medical Concepts announced successful completion of the first case utilizing its Lapiplasty Lightning technology.
Lightning technology expands upon Treace’s Lapiplasty System with advanced new instrumentation designed to reduce surgical steps, correct in all three planes, and further streamline procedural workflow with Treace’s...
Treace Medical Concepts announced successful completion of the first case utilizing its Lapiplasty Lightning technology.
Lightning technology expands upon Treace’s Lapiplasty System with advanced new instrumentation designed to reduce surgical steps, correct in all three planes, and further streamline procedural workflow with Treace’s SpeedPlate Rapid Compression Fixation technology.
“As the pioneers and leaders in instrumented 3D bunion correction, Lightning technology demonstrates our commitment to continuous advancement of our patented Lapiplasty® System, improving surgical efficiency and precision and expanding its appeal to more surgeons,” said John T. Treace, CEO and Chairman of Treace. “We anticipate initiating our limited market release of the Lapiplasty® Lightning™ System midyear 2026 in advance of full commercialization, which we expect before the end of year.”
Copy to clipboard 
